Search
Search Constraints
You searched for: Author/Creator Mielants, HLimit your search
- Mielants, H [remove] 45
- 616.723005 41
- Rheumatism -- Periodicals 41
- 616.33 4
- Gastroenterology -- Periodicals 4
- ACPA, anti-citrullinated protein/peptide antibodies -- CCP, cyclic citrullinated peptide -- DIP, distal interphalangeal joint -- ESSG, European Spondyloarthropathy Study Group -- pepA, peptide A -- pepB, peptide B -- RF, rheumatoid factor -- RXJC, radiological joint count -- SJC, swollen joint count 1
- ACR, American College of Rheumatology -- CCP, cyclic citrullinated peptide -- RA, rheumatoid arthritis -- RF, rheumatoid factor -- ROC, receiver operating characteristic -- SE, shared epitope 1
- ANA, antinuclear antibodies -- AS, ankylosing spondylitis -- CD, Crohn's disease -- CRP, C reactive protein -- CT, computed tomography -- DMARD, disease modifying antirheumatic drug -- ESR, erythrocyte sedimentation rate -- HACAs, human antichimeric antibodies -- IV, intravenously -- NSAIDs, non-steroidal anti-inflammatory drugs -- PsA psoriatic arthritis -- RA, rheumatoid arthritis -- ReA, reactive arthritis -- SpA, spondyloarthropathy -- TNFα, tumour necrosis factor α, uSpA, undifferentiated spondyloarthropathy 1
- ANA, antinuclear antibodies -- AS, ankylosing spondylitis -- CRP, C reactive protein -- ESR, erythrocyte sedimentation rate -- PsA, psoriatic arthritis -- RA, rheumatoid arthritis -- SpA, spondyloarthropathies -- TNFα, tumour necrosis factor α -- uSpA, undifferentiated spondyloarthropathy -- VAS, visual analogue scale 1
- ANOVA, analysis of variance -- AS, ankylosing spondylitis -- B, Belgium -- BASDAI, Bath Ankylosing Spondylitis Disease Activity Index -- BASFI, Bath Ankylosing Spondylitis Functional Index -- CI, confidence interval -- EQ-5D, EuroQol 5 dimensions instrument -- F, France -- FC -- friction costs -- HC, human capital -- IBD, inflammatory bowel disease -- NL, the Netherlands -- OR, odds ratio -- QoL, quality of life -- RA, rheumatoid arthritis 1
- ANOVA, analysis of variance -- AS, ankylosing spondylitis -- BASDAI, Bath Ankylosing Spondylitis Disease Activity Index -- BASFI, Bath Ankylosing Spondylitis Functional Index -- COI, cost of illness -- CT, computed tomography -- DMARD, disease modifying antirheumatic drug -- HR, hazard ratio -- IBD, inflammatory bowel disease -- NSAID, non-steroidal anti-inflammatory drug -- RA, rheumatoid arthritis 1